Filing metadata

Accession number
0001127602-23-018065
Form type
Form 4
Filer
Apellis Pharmaceuticals, Inc.
CIK
CIK 1492422
Filed
Jun 06, 2023
Reporting period
Jun 05, 2023
Description
Insider transaction

Explore SEC Filings Hub